Sanguine Media closes trading window from Oct 1 for Q2FY27 results

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Trading window closes from October 1, 2026, for Sanguine Media Limited
  • Restriction covers promoters, directors, KMPs, and connected persons
  • Window reopens 48 hours after Q2FY27 results declaration
  • Compliance mandated under SEBI (Prohibition of Insider Trading) Regulations, 2015
powered bylight_fuzz_icon
52226290

*this image is generated using AI for illustrative purposes only.

Sanguine Media Limited closed its trading window on Thursday, October 1, 2026. This action precedes the declaration of unaudited financial results for the quarter ended September 30, 2026. The closure restricts insiders from dealing in the company's securities during this period.

The restriction applies to promoters, members of the promoter group, directors, key managerial personnel, and designated persons. It also extends to their immediate relatives and connected persons. The window will remain closed until 48 hours after the results are declared.

Regulatory compliance and scope

The company cited Clause 4(2) of Schedule B read with Regulation 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Additional references include SEBI Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022, and SEBI/HO/ISD/ISD-POD-2/P/CIR/2023/124 dated July 19, 2023.

All designated persons are advised not to enter into any transaction involving the securities of the company during the closure period. The company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons governs these restrictions.

Upcoming board meeting

The date for the board meeting to approve the financial results will be announced in due course. The filing was submitted to the BSE Limited by Aditya R Suryavanshi, Director, on September 28, 2026.

How might the upcoming unaudited financial results for Q2 FY2027 impact Sanguine Media's stock volatility once the trading window reopens?

What specific revenue drivers or cost efficiencies is the market expecting from Sanguine Media to justify potential valuation adjustments post-results?

Will the delayed announcement of the board meeting date signal any internal governance challenges or strategic delays in the company's reporting cycle?

like17
dislike

Sanguine Media submits FY26 annual report, cuts net loss to ₹0.41 lakh

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Net loss reduced to ₹0.41 lakh in FY26 from ₹15.98 lakh in FY25
  • Total income declined to ₹9.53 lakh from ₹12.25 lakh in the previous year
  • 31st AGM scheduled for September 30, 2026, to adopt accounts and re-appoint MD
  • Company remains suspended from trading due to unpaid BSE listing fees
powered bylight_fuzz_icon
52210923

*this image is generated using AI for illustrative purposes only.

Sanguine Media Limited has submitted its 31st Annual Report for the financial year ended March 31, 2026, to BSE Limited. The filing reveals a narrowed net loss of ₹0.41 lakh, compared to a loss of ₹15.98 lakh in the previous year.

The company’s total income for FY26 stood at ₹9.53 lakh, down from ₹12.25 lakh in FY25. Despite the decline in revenue, the reduction in expenses led to a substantial decrease in the deficit carried to the balance sheet. The Board of Directors has not recommended any dividend for the period.

Financial performance and operational status

The Directors’ Report highlights that the company is engaged in film production, distribution, and exhibition. During the year under review, the company did not borrow any loans from banks. The paid-up equity share capital remained unchanged at ₹11.41 crore.

Particulars FY26 (₹ lakh) FY25 (₹ lakh)
Gross Sales/Income 9.53 12.25
Profit/(Loss) before Tax (0.41) (15.98)
Profit/(Loss) After Tax (0.41) (15.98)

The statutory auditor, K.S. Subrahmanyam & Co., issued an unmodified audit report, confirming that the financial statements represent a true and fair view of the company's state of affairs.

AGM and director re-appointment

Sanguine Media will hold its 31st Annual General Meeting on Wednesday, September 30, 2026, at its registered office in Chennai. The agenda includes the adoption of audited financial statements and the re-appointment of Sanjay Sunderlal Meena as Director (Executive). Meena retires by rotation and offers himself for re-appointment under Section 152(6) of the Companies Act, 2013.

Shareholders may cast votes electronically via NSDL. The remote e-voting period begins on September 27, 2026, at 9:00 am and ends on September 29, 2026, at 5:00 pm. The cut-off date for voting rights is September 23, 2026.

Compliance and governance updates

The Secretarial Audit Report noted several compliance lapses, including non-payment of listing fees to BSE and non-filing of annual returns with the Registrar of Companies for three consecutive years. The company stated it is in the process of rectifying these issues. Additionally, the company remains suspended from trading due to non-payment of annual listing fees.

The Board comprises four directors: Sanjay Sunderlal Meena (Managing Director), Aditya R Suryavanshi, Akshay Nawale, and Gayatri Gupta. No changes occurred in the board composition during the year. The company has no subsidiaries or joint ventures.

Will Sanguine Media successfully clear its outstanding listing fees and compliance lapses to resume trading on the BSE?

How does the company plan to reverse the declining revenue trend in its film production and distribution segments?

What specific operational cost reductions were implemented to narrow the net loss from ₹15.98 lakh to ₹0.41 lakh?

like19
dislike

More News on Sanguine Media Limited